Document text
Principal Investigator: Susan Daniel
Organization: CORNELL UNIVERSITY
Fiscal Year: 2020
Award: $87,264
Funding agency: National Institute of Allergy and Infectious Diseases
Project Summary / Abstract
Enveloped viruses access their host cells by binding to receptors on the plasma membrane and then undergoing
fusion with the host membrane. Both binding and fusion are mediated by a specific viral “spike” protein that is
typically primed for fusion activation by proteolytic cleavage to expose the fusion peptide. Coronavirus fusion
spike protein (CoV S) is a complex biomolecular machine that has a novel fusion peptide with has a great deal
of inherent flexibility in its fusion reaction. This is exploited by these viruses in their diverse entry pathways and
is a primary determinant of viral tropism. We have pioneered the concept that that the proteolytic cleavage events
in S that lead to membrane fusion occur both at the interface of the receptor binding (S1) and fusion (S2) domains
(called S1/S2), as well as adjacent to a structurally and functionally novel fusion peptide within S2 (called S2’).
Thus, there are notable differences between CoV S and most other class I fusion proteins including: 1) that the
proteolytic events liberating the fusion peptide are diverse, and 2) that the fusion peptide itself is atypical in
sequence compared to other fusion peptides, containing a mixture of important hydrophobic and negatively-
charged residues, and may represent a larger than normal fusion “platform” instead of a defined “peptide”. Thus
fusion peptide activity is likely controlled by reorganization of the fusion platform, based on both hydrophobic
(i.e. lipid-binding) and ionic (i.e. Ca2+ and pH) interactions. Despite the recent availability of two S structures,
there remains a very limited mechanistic understanding of membrane fusion for the CoV family, or any structural
information to correlate structural biology aspects of S to its function in membrane fusion. This information is
critical to understanding viral pathogenesis and CoV emergence into the human population. We propose to
develop a panel of monoclonal antibodies to the SARS-CoV-2/COVID-19 fusion peptide that will be used as tools
to understand the fusion mechanism of coronaviruses, and which will be integrated into our biophysical,
biochemical, and in vivo approach to study the unique cleavage-activated regulation of CoV S protein. These
antibodies will also provide a platform for development of novel broadly-acting therapeutic antibodies for SARS-
CoV-2 and other coronaviruses. Moving the field forward with these innovative studies will provide critical
knowledge about CoV entry and tropism needed to safeguard human health from an emerging pathogen likely
to cause severe outbreaks, and for which few or no medical countermeasures exist.
Terms: <2019 novel coronavirus><2019-nCoV><Animals><Antibodies><Binding><Biochemical><Biophysics><Body Tissues><COVID-19><COVID19><Cell Body><Cell membrane><Cells><Charge><Chimera Protein><Chimeric Proteins><Clinical Treatment Moab><CoV S protein><CoV emergence><CoV glycoprotein S><CoV spike glycoprotein><CoV spike protein><Communicable Diseases><Complex><Coronaviridae><Coronaviridae Infections><Coronavirus><Coronavirus Infections><Coronavirus glycoprotein S><Coronavirus spike protein><Cytoplasmic Membrane><Data><Development><Disease Outbreaks><Environment><Esteroproteases><Event><Exposure to><Family><Fusion Protein><Goals><Health><Human><Hydrophobicity><Infectious Disease Pathway><Infectious Diseases><Infectious Disorder><Investigators><Ions><Knowledge><Lead><Lipid Binding><MERS><MERS corona virus><MERS coronavirus><MERS coronavirus disease><MERS virus><MERS-CoV><MERS-CoV disease><Mediating><Membrane><Membrane Fusion><Methods><Middle East Respiratory Syndrome><Middle East Respiratory Syndrome CoV disease><Middle East Respiratory Syndrome Corona Virus><Middle East Respiratory Syndrome Coronavirus><Middle East Respiratory Syndrome Virus><Middle East Respiratory Syndrome coronavirus disease><Middle East Respiratory Syndrome-CoV><Middle Eastern Respiratory Syndrome><Middle Eastern Respiratory Syndrome CoV disease><Middle Eastern Respiratory Syndrome Corona virus><Middle Eastern Respiratory Syndrome Coronavirus><Middle Eastern Respiratory Syndrome Virus><Middle Eastern Respiratory Syndrome coronavirus disease><Middle Eastern Respiratory Syndrome-CoV><Modern Man><Molecular Interaction><Monitor><Monoclonal Antibodies><Nature><Outbreaks><Pathogenesis><Pathway interactions><Pb element><Peptidases><Peptide Domain><Peptide Hydrolases><Peptides><Plasma Membrane><Play><Population><Process><Property><Protease Gene><Proteases><Protein Domains><Proteinases><Proteins><Proteolytic Enzymes><Reaction><Receptor Protein><Regulation><Research Personnel><Research Resources><Researchers><Resources><Role><SARS><SARS Virus><SARS corona virus><SARS coronavirus><SARS coronavirus disease><SARS-Associated Coronavirus><SARS-CoV><SARS-CoV disease><SARS-CoV-2><SARS-CoV2><SARS-Related Coronavirus><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related coronavirus 2><Severe Acute Respiratory Syndrome><Severe Acute Respiratory Syndrome CoV disease><Severe Acute Respiratory Syndrome Virus><Severe Acute Respiratory Syndrome corona virus><Severe Acute Respiratory Syndrome coronavirus><Severe Acute Respiratory Syndrome coronavirus disease><Severe acute respiratory syndrome coronavirus 2><Structure><Techniques><Tertiary Protein Structure><Therapeutic><Therapeutic antibodies><Tissues><Transmission><Tropism><Viral><Viral Fusion Proteins><Viral Pathogenesis><Viral Receptor><Virus><Virus Receptors><Wuhan coronavirus><Zoonoses><Zoonotic><Zoonotic Infection><base><biophysical foundation><biophysical principles><biophysical sciences><cell type><corona virus><corona virus disease 2019><coronavirus S protein><coronavirus disease 2019><coronavirus emergence><coronavirus spike glycoprotein><developmental><emergent CoV><emergent coronavirus><emerging CoV><emerging coronavirus><experiment><experimental research><experimental study><flexibility><flexible><heavy metal Pb><heavy metal lead><in vivo><innovate><innovation><innovative><lipid bound><mAbs><medical countermeasure><membrane structure><mouse model><murine model><nCoV><neutralizing mAb><neutralizing monoclonal antibodies><new CoV><new coronavirus><novel><novel CoV><novel coronavirus><particle><pathogen><pathway><plasmalemma><protein function><receptor><receptor binding><receptor bound><severe acute respiratory syndrome-CoV><social role><structural biology><tool><transmission process><virus envelope><virus pathogenesis>